Insiders Delta-Fly Pharma, Inc.

Equities

Delayed Japan Exchange Other stock markets 11:30:00 16/05/2024 am IST			5-day change	1st Jan Change
565 ^JPY	-20.98%		-21.42%	-44.33%

08/04	Delta-Fly Pharma Inc. Receives Notice of Authorization to Conduct the Phase I/II Study of DFP-10917 Combined with Venetoclax	CI
11/03	Delta-Fly Pharma Inc. Announces FDA Submission of the Protocol of the Phase I/II Study of DFP-10917 Combined with Venetoclax in the AML Patients Treated by VTX in the AML	CI

No results for this search